Healthcare

ForbesSocial Media

Follow Forbes Healthcare

More From Healthcare

article image

Rotavirus Is Surging Across The United States—Here’s What Parents Need To Know

A doctor discusses what parents need to know to keep their kids safe amid the surge of Rotavirus cases across the U.S.

ByOmer Awan,

Senior Contributor

article image

The Most Dysfunctional Leadership Habit In Healthcare: ‘Split The Baby’ Thinking

Many healthcare organizations are dominated by cultures of compromise and consensus. And maybe that’s why they never really get better.

BySachin H. Jain,

Contributor

article image

‘Bedtime Stacking’ Trends On TikTok. Here Are The Risks

Various TikTokers have been pushing something called “bedtime stacking” or "sleep stacking" as an efficiency and comfort hack. But is this a good idea?

ByBruce Y. Lee,

Senior Contributor

article image

Why Do Weight Loss Drugs Work For Some And Not Others? It’s In The Genes

Variants in GLP‑1 and GIP receptor genes partly determine weight loss and nausea risk on GLP‑1 drugs, signaling a shift from one‑size‑fits‑all treatment.

ByWilliam A. Haseltine,

Contributor

article image

Medical Errors Happen Daily: What Patients Need To Know

Hospital safety isn’t guaranteed. Learn the real risks of medical errors and how patients can protect themselves with smarter healthcare decisions.

ByJohn Samuels,

Contributor

article image

Medicare Can Save $4 Billion On Four Cancer Drugs — Can You Guess Which Ones?

Medicare drug price negotiations on cancer alone could save billions

ByPeter Ubel,

Contributor

article image

After 25 Years Of Consumer-Directed Healthcare, What’s Missing?

Why consumer-directed healthcare hasn’t delivered, and how stronger price signals, better data and new tools could finally make patients better shoppers.

ByAnthony T. Lo Sasso,

Contributor

article image

This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster

Formation Bio CEO Ben Liu is convinced that drug discovery isn’t the bottleneck in getting medicines to market—it’s going through clinical trials. Now he’s raised some $615 million from top investors to buy stalled drugs and use AI to stress test them faster.

ByAmy Feldman,

Senior Editor

article image

RFK Jr. Pushes To Expand Access To Peptides. A Doctor Explains The Risks

A physician examines whether the FDA's loosening of wellness peptide restrictions means these compounds are actually safe and proven. The answer may surprise you.

ByJesse Pines,

Contributor

article image

How The Trump Administration Is Blocking Access To Home Care

Trump promises maximum consumer choice in health care. Yet, he is making it harder to access home -based care favored by older adults and young people with disabilities.

ByHoward Gleckman,

Senior Contributor